An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Afya Limited (NASDAQ: AFYA) will announce its Second-Quarter and First Half 2022 Financial Results on August 22, 2022, after market close. The conference call is scheduled for 5:00 PM ET and will be accessible via webcast. The company also disclosed sell-side analysts’ consensus figures, with estimated Net Revenue ranging from R$ 554 million to R$ 573 million and Adjusted EBITDA expected between R$ 211 million and R$ 224 million. The estimates were based on forecasts collected from analysts between July 15 and July 21, 2022.
Positive
Analysts' consensus for Net Revenue is between R$ 554 million and R$ 573 million, indicating a stable revenue outlook.
Estimated Adjusted EBITDA ranges from R$ 211 million to R$ 224 million, suggesting a healthy earnings potential.
Negative
None.
NOVA LIMA, Brazil--(BUSINESS WIRE)--
Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report Second-Quarter and First Half 2022 Financial Results for the period ended June 30, 2022, following the close of the market on Monday, August 22nd, 2022 and will host a corresponding conference call and webcast at 05:00 pm ET.
A live and archived webcast of the call will be available on the Investor Relations section of the Company’s website at https://ir.afya.com.br/.
To participate in Afya’s Second-Quarter and First Half 2022 conference call, please follow the instructions below:
Afya also announces today the publication of its 2Q22 sell-side analysts’ consensus figures. The consensus figures are based on the forecasts of analysts who follow Afya results on a regular basis. This information was collected between July 15, 2022 and July 21, 2022, directly from the sell-side analysts.
These firms follow Afya on their own initiative and Afya is not responsible for their views. Afya is neither involved in the collection of the information nor in the compilation of the estimates.
R$ Million
Bank 1
Bank 2
Bank 3
Bank 4
Bank 5
Bank 6
Average
Median
Net Revenue
562
567
565
557
573
554
563
564
Adjusted EBITDA
213
217
217
224
211
211
216
215
Adjusted EBITDA Margin
38%
38%
38%
40%
37%
38%
38%
38%
Disclaimer
The consensus estimate is based on estimates, forecasts and predictions made by third party financial analysts. It is not prepared based on information provided or checked by Afya and can only be seen as a consensus view on Afya’s results from an outside perspective. Afya has not provided input on these forecasts, except by referring to past publicly disclosed information. Afya does not accept any responsibility for the quality or accuracy of any individual forecast or estimate. This press release may contain forward-looking statements based on current assumptions and forecasts made by Afya or third parties. Various known and unknown risks, uncertainties and other factors could lead to material differences between Afya’s actual future results, financial situation, development or performance, and the estimates given here. Further information on these and other factors that could affect our financial results is included in filings we make with the Securities and Exchange Commission from time to time, including the section titled “Risk Factors” in our most recent Rule 424(b) prospectus. These documents are available on the SEC Filings section of the investor relations section of our website at: https://ir.afya.com.br/.
About Afya:
Afya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering digital products to help doctors enhance their healthcare services through their whole career.
